Covid vaccine contracts: EU has hands tied, experts say

The clash between the EU and AstraZeneca over delayed vaccines has revealed a stack of questionable contracts signed with Big Pharma. Potential problems include manufacturers’ ambiguous delivery dates, and uncertainty about the immunisation schedule for the European population. Lawyers investigating the deals show that companies have a clear advantage over the EU.